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Edited by Sandro SonninoAbstract Transgenic mouse models of hemoglobinopathies
unravel pathophysiological mechanisms; yet the validity of the
red blood cell (RBC) model of human hemoglobin (hHb) envel-
oped by a mouse (m) membrane has been questioned. Isoelectric
focusing of hHb and mHb from transgenic mRBC shows a great-
er association of mHb to the mouse membrane compared to
normal hHbA, supporting a species-speciﬁc Hb-mRBC mem-
brane interaction. Enhanced hmutant Hb (HbE, HbS and
HbC)-mRBC membrane aﬃnities correlates with enhanced
membrane lipid peroxidation and parallel those reported in
hRBC, lending support to transgenic mRBC as models of hemo-
globinopathies. Species-speciﬁc Hb-membrane interaction may
be overridden by Hb charge and conformational alterations.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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focusing1. Introduction
Hemoglobin (Hb) association with the red blood cell (RBC)
membrane is highly relevant to the understanding of normal
RBC regulatory processes, such as glycolysis [1,2]. In hemoglo-
binopathies, the association of mutant Hbs [3–5] and their oxi-
dation/degradation products, hemichromes and hemin, are
linked to membrane damage. Unstable hemoglobins (e.g.,
HbS andHbE) and excess a-globin chains in b-thalassemia, give
rise to reactive oxidative species with subsequent damage to the
RBC membrane [5–9]. These phenomena appear to be acceler-
ated with enhanced binding of unstable Hbs to the membrane.
It is established that humanhemoglobin (hHb)binds tohuman
cytosolic band 3 (cB3H) of the RBC membrane with an aﬃn-Abbreviations: Hb, Hemoglobin(s); hHb, human hemoglobin; mHb,
mouse hemoglobin; HbMsingle, mouse single hemoglobin; IEF, iso-
electric focusing; cB3H, human cytosolic band 3; cB3M, mouse
cytosolic band 3; RBC, red blood cell(s); O2, oxygen; DPG, 2,3-di-
phosphoglycerate; aM, mouse a-globin; bmin, mouse b-minor globin;
bMsingle, mouse b-single globin
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doi:10.1016/j.febslet.2006.07.021ity dependent upon the Hb variant [HbC (b6Lys) > HbA2
(a2d2) > HbS (b6Val) > human adult Hb [HbA (b6Glu)]] [2–
4]. Band 3, an anion transmembrane glycoprotein, includes a
cytoplasmic domain serving as an anchor of the membrane
cytoskeleton and several cytoplasmic proteins (e.g., ankyrin,
various glycolytic enzymes, Hb). Crystallographic evidence
shows that the cB3H N-terminus binds to the Hb central cav-
ity, including residues that bind 2,3 diphosphoglycerate (DPG)
[10]. Considerable diﬀerences exist in the N-terminal sequence
of mouse cB3 (cB3M) compared to cB3H (Scheme 1) [1,11,12].
Since (1) cB3/Hb interactions are of physiological importance
across species [11] and (2) the displacement of a ﬂuorescent
DPG analog from the Hb central cavity by mouse and human
cB3 11 amino acid peptides appeared to be species-speciﬁc [13],
the association of hHb with the mRBC membrane in trans-
genic mice expressing hHb needs to be addressed.
In the present study, a comparison of hHb and mouse hemo-
globin (mHb) association with mRBC membranes was con-
ducted using RBC from transgenic mice expressing both
normal hHbA, human Hb variants and mouse single Hb
(HbMsingle). The aﬃnity of HbMsingle to the mRBC membrane
is greater than HbA but smaller than the human mutants HbE,
HbS and HbC. This enhanced association of the hHb mutants
with mRBC parallels the established enhanced binding of b6
mutant Hb to the hRBC membrane compared to hHbA
[5,14,15], and is correlated with membrane lipid peroxidation.
The results suggest that, in mouse and humans, the relative
association of Hb to the RBC membrane is dependent upon
a species-speciﬁc interaction that may be overridden by charge
and conformation alterations in mutants.2. Materials and methods
2.1. Transgenic mice
Transgenic mice expressing both hHbA and HbMsingle, or exclu-
sively hHbE, hHbA/hHbE, hHbA/hHbE, hHbA/hHbE were generated
as described [16–18]. These mice were generated on a FVB mouse
background and then bred on a C57/BL (C57) background. The
C57 mouse expresses HbMsingle consisting of one mouse a-single globin
chain (aM) and one mouse b-single globin chain (bMsingle). The FVB
mHb consists of multiple mouse a and b globin chains: mouse a1
(aM1), a3 (aM3), b-major, b-minor, and b-single (bMsingle). The Hb spe-
cies present transgenic mRBC depend on the genotype (Figs. 1 and 2).2.2. Hb association with the mRBC membrane
Washed mRBC were lysed in 12:1 volume of distilled water:packed
RBC. The lysates were centrifuged to obtain ‘‘Supernatant 1’’ (i.e., the
RBC hemolysate, designated ‘Super 1’), which contains cytosolic (non-
membrane-associated) Hbs. The membrane fraction was separated andblished by Elsevier B.V. All rights reserved.
11 amino acid N-terminal region of Human Band 3 [1] 
AcMet-Glu-Glu-Leu-Gln-Asp-Asp-Tyr-Glu-Asp-Glu
11 amino acid N-terminal region of Mouse Band 3 [11-12] 
AcMet-Gly-Asp-Met-Arg-Asp-His-Glu-Glu-Val-Leu
* Identical residues are indicated by bold while italics indicate similar charge. 
Scheme 1. A comparison of the 11 amino acid N-terminal region of mouse and human cytosolic band 3.
Fig. 1. mHb exhibits a greater association with the mRBC membrane than does hHbA. A comparison of hHbA and HbMsingle association with the
mRBC membrane of the transgenic mouse expressing hHbA and mHb is presented. Genotype aHbAaMKbMK denotes the HbA transgenic mouse with
partial mouse a and mouse b globin knockouts. IEF of Hbs contained in transgenic mRBCs is shown on the left. Shown in the right lane is the
remaining Hb bound to the membrane that was removed by Supra-heme (see Section 2). aH2 b
Msingle
2 and a
M
2 b
A
2 are chimeric hemoglobins of human and
mouse globin chains assembled in vivo.
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supernatant. Membranes were extracted with Supre-Heme buﬀer
(tris-EDTA-boric acid buﬀer, pH 8.2–8.6) (Helena Labs, TX). The
supernatant obtained from the Supre-Heme extraction was labeled
‘‘Supernatant 2’’ (‘Super 2’) and contains the membrane-associated Hb.
Super 1 and 2 were analyzed by isoelectric focusing (IEF) (Isolab,
Akron, OH) to compare the percent Hb composition in the hemolysate
(Super 1) and in membrane-associated Hbs (Super 2). The relative
intensity of each focused Hb band (Hb tetramer) was quantiﬁed by
ImageQuant TL (GE Healthcare (Amersham Biosciences), NJ). The
percentage of the individual Hb band in Super 1 and Super 2 was cal-
culated. Changes in the relative Hb percentage comparing Super 2 to
Super 1 indicate diﬀerential association of the Hb variants with the
membrane.
2.3. RBC membrane lipid peroxidation
A ﬂuoresceinated phosphoethanolamine-based ﬂow-cytometry
method [19–21] is used to detect lipid peroxidation. Washed mRBC
were suspended in mouse saline (1 · 106 cell/ml) and incubated with
50 lM ﬂuorescein-dihexadecanoyl-phosphatidylethanolamine (Fluor-
DHPE, Molecular Probes, Eugene, OR) at 37 C for 1 h as described
by Amer et al. [21]. mRBC were ﬁrst washed (to remove unbound
probe) and then incubated at room temperature for 1–2 h prior to ﬂow
cytometry using a Becton-Dickinson FACS Scan with analysis by
Cytomation Summit software (V. 3.1), CO.3. Results
3.1. In situ human and mHb association with transgenic
mRBC membranes
hHbA and HbMsingle exhibit diﬀerential association with the
transgenic mRBC membrane (Fig. 1). Comparing Super 1 toSuper 2, the percentage of hHbA decreases (from
28.5 ± 3.5% to 10.5 ± 3.5%), while the percent composition
of mHb exhibits an insigniﬁcant change (44.5 ± 6.4% to
46.0 ± 7.1%) (Table 1). The ratio of HbMsingle to hHbA in
membrane-associated Hb is signiﬁcantly greater than that in
the hemolysate (P < 0.05, Table 1), demonstrating an en-
hanced association of HbMsingle with mRBC membranes.
Since phosphate is known to bind to the Hb central cavity
[22], it is noteworthy (discussed below) that RBC lysed and
washed with 5 mM phosphate buﬀer (pH 7.35) [23,24] showed
no detectable membrane-associated Hb (data not shown), in
contrast to the 5 mM HEPES (pH 7.35) or distilled water
membrane preparations.
3.2. Human mutant Hbs exhibit enhanced association with
mRBC membranes than HbMsingle and hHbA
A signiﬁcantly increased hHbE/hHbA and hHbC/hHbA
ratio in membrane-associated Hb is observed in hemolysates
derived from transgenic mice expressing exclusively hHbA/
hHbE and hHbA/hHbC (P < 0.03, Table 1, Fig. 2a and
b). The enhanced association of hHbE and hHbC with the
mRBC membrane is similar to that reported for respective
human mutant RBC [5,23,25–28]. To compare hHb mutants
and HbMsingle association with the mRBC membrane, RBC
from partial knockout mice expressing multiple mHbs and a
speciﬁc hHb mutant were analyzed (Fig. 2d and e). hHbE
and hHbC exhibit enhanced mRBC membrane association
compared to HbMsingle (Table 1). While a direct comparison
of HbMsingle and hHbS cannot be made because of their
Table 1
Relative Hb composition in transgenic mouse RBC hemolysates and membranes
Mouse genotype N Hb variant % Hb in
hemolysate
% Hb membrane
associated
R1 (hemolysate
Hb)
R2 (membrane
associated Hb)
P value R1 versus
R2 (2-tailed)
aHbAaMKbMK 2 Hb#1 Hb Msingle 44.5 ± 6.4 46.0 ± 7.1
Hb#2 hHbA 28.5 ± 3.5 10.5 ± 3.5 1.59 ± 0.42 4.52 ± 0.85 P < 0.05
aHbAbE 3 Hb#1 hHbE 39.3 ± 1.2 74.7 ± 6.4
Hb#2 hHbA 60.7 ± 1.2 25.3 ± 6.4 0.65 ± 0.03 3.15 ± 1.22 P < 0.03
aHbAbC 3 Hb#1 hHbC 50.0 ± 0.0 90.3 ± 1.5
Hb#2 hHbA 50.0 ± 0.0 9.7 ± 1.5 1.00 ± 0.00 9.53 ± 1.76 P < 0.002
aHbSbE 3 Hb#1 hHbS 61.7 ± 4.7 58.7 ± 1.2
Hb#2 hHbE 38.3 ± 4.7 41.3 ± 1.2 1.64 ± 0.34 1.42 ± 0.07 P < 0.4 (NS)
aHbEaMbMK 3 Hb#1 Hb Msingle 32.3 ± 15.9 11.3 ± 2.5
Hb#2 hHbE 32.0 ± 8.9 77.3 ± 4.6 0.99 ± 0.47 0.15 ± 0.04 P < 0.04
aHbCaMKbMK 3 Hb#1 Hb Msingle 22.7 ± 0.6 3.3 ± 4.0
Hb#2 hHbC 48.0 ± 1.7 90.3 ± 8.1 0.47 ± 0.03 0.05 ± 0.03 P < 0.00007
See Figs. 1 and 2 for genotype descriptions. R1 and R2, the relative ratio of Hb
#1/Hb#2 for hemolysate Hb and membrane associated Hb, respectively.
NS, non-signiﬁcant.
Fig. 2. Enhanced association of hHb variants HbE, HbS and HbC with the mRBC membrane than hHbA and mHb. Hb association with the RBC
membrane from mRBC obtained from transgenic mice expressing (a) exclusively hHbA and hHbE (genotype: aHbAbE); (b) exclusively hHbA and
hHbC (genotype: aHbAbC); (c) exclusively hHbS and hHbE (genotype: aHbSbE); (d) hHbE and mHb (genotype: aHbEaMbMK); and (e) hHbC and
mHb (genotype: aHbCaMKbMK). See descriptions in Fig. 1 for genotype.
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mRBC membrane appears comparable to hHbE as
observed in hHbS/hHbE transgenic mRBC (P < 0.4, Table
1, Fig. 2c).3.3. RBC membrane lipid peroxidation is increased in mRBC
containing human mutant Hb
Since it is well established that RBC membrane lipid per-
oxidation is heightened in hemoglobinopathies (e.g. [6]), lipid
Fig. 3. Flow cytometry shows enhanced membrane lipid peroxidation (decreased mean ﬂuorescence intensity) in transgenic mRBC expressing human
mutant Hb compared to C57. (a–f) Forward scatter – mean ﬂuorescence intensity dot plots of mRBC labeled with Fluor-DHPE. g: The average mean
ﬂuorescence intensity of transgenic mRBC expressing diﬀerent human mutant Hbs (n = 2–5, for each genotype). These mice are full mouse globin
knockouts except for hHbS/hHbF mice that are partial mouse b globin knockouts containing 10% human fetal Hb (hHbF). HbF ameliorates the
severity of sickle cell disease, as also shown in transgenic mice [18].
4488 Q. Chen et al. / FEBS Letters 580 (2006) 4485–4490peroxidation assays were performed on RBC from the HbE
mouse RBC compared to C57, using a ﬂuoresceinated phos-
phoethanolamine-based ﬂow-cytometric method [19–21].
Fluor-DHPE is lipophilic and its ﬂuorescence is primarily
observed on the outer membrane leaﬂet. Fluo-DHPE ﬂuo-
rescence is quenched upon interaction with membrane per-
oxyl radicals (ROO) or hydroperoxide (ROOH) [20]. The
two-parameter dot plots (forward scatter versus green ﬂuo-
rescence (FL1), Fig. 3a–f) show (1) mRBC with human mu-
tant Hbs exhibit a lower Fluo-DHPE ﬂuorescence intensity
compared to C57, indicating enhanced lipid peroxidation;
and (2) signiﬁcant microcytosis, reﬂected by a smaller for-
ward scatter, particularly in hHbC and hHbE mRBC. The
mean ﬂuorescein ﬂuorescence intensity of human mutant
mRBC is signiﬁcantly decreased compared to C57
(P < 0.01, Fig. 3g).4. Discussion
Transgenic mouse models of hemoglobinopathies are impor-
tant in deﬁning mechanisms of pathophysiology and in the
design of ameliorating therapies [27]. In transgenic hemoglo-
binopathy mouse models, membrane oxidative damage and
premature RBC destruction are reﬂected by elevated reticulo-
cytes levels and lower hematocrits [17,18,28]. Yet, the validity
of the RBC model of human Hb encased in a mouse mem-
brane has been questioned. The utility of hHbS, hHbC and
hHbE transgenic mRBC models is supported by the following:
enhanced association of hHbE, hHbS and hHbC with the
mRBC membrane compared to hHbA and HbMsingle are con-
sistent with the known higher aﬃnity of these hHbs to the
hRBC membrane. Increased mutant Hb-membrane associa-
tion is correlated and consistent with hematologic parameters
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transgenic models [17,18,28]. In humans, it is also well estab-
lished that hemoglobinopathies, exhibiting increased associa-
tion with the RBC membrane, also show increased
membrane lipid peroxidation [6,29]. Consistently, enhanced
membrane lipid peroxidation is correlated with enhanced
Hb-membrane association in mRBC containing human mu-
tant Hb (hHbChHbEhHbS/hHbE >> C57, Fig. 3).
The enhanced HbMsingle association with mRBC mem-
branes (compared to hHbA) (Fig. 1) lends support to the no-
tion of species-speciﬁc Hb-membrane association proposed
by Weber et al. [1] showing a respective species-speciﬁc oxygen
(O2) aﬃnity response for ﬁsh, bird, chicken and hHb. Yet, this
species-speciﬁcity is not seen with the hHb mutants (Fig. 2).
This apparent paradox may be due to known charge and con-
formational alterations in hHb mutants [13] that override the
Hb-membrane species-speciﬁc interaction. This is reﬂected in
the observation that aM2 b
A
2 is not associated tightly with the
membrane (Fig. 1), indicating that the species-speciﬁc interac-
tion is conferred by the b-chain.
Our ﬁnding that phosphate buﬀer minimizes Hb association
with the membrane (data not shown) is consistent with the role
of the Hb central cavity in membrane association since phos-
phate binds at the Hb bb cleft [30], the DPG binding site
and the N-terminus of cB3 binding site [10]. Therefore, spe-
cies-speciﬁc Hb-membrane association may be explained not
only by complementary sequence and charge, but also by the
bb cleft conformational diﬀerences in these Hbs [31]. Given
the diﬀerences in the mHb sequence at sites other than the cen-
tral cavity, a long-range communication of conformational
change to the mHb central cavity may contribute to the diﬀer-
ences in Hb-membrane association, as well as a diﬀerence in
the cB3M conformation compared to the human counterpart
endowing the observed species-speciﬁc interaction. It is possi-
ble that the sequence and/or conformation of the Hb central
cavity must be matched with that of cB3, raising the possibility
of a co-evolution of band 3 with the Hb central cavity and the
likelihood of a physiological role for the Hb/band 3 interaction
as proposed by Weber et al. [1].
It is important to consider the multitude of factors that com-
plicate Hb-membrane association. For example, it is possible
that diﬀerences in Hb-membrane association could arise from
the variations in contents of mRBC and hRBC (e.g., DPG, en-
zymes, divalent ions, pH, ATP) [1]. Several glycolytic enzymes
or other enzymes/proteins, not found/present in varying pro-
portions in the hRBC compared to mouse, could bind to
cB3 in a competitive fashion that diﬀers between these species
[1]. It is known the DPG content diﬀers in mRBC compared to
hRBC [32]. DPG also diﬀers in its modulation of the O2 bind-
ing aﬃnity of mHb compared to hHb [33], which further sup-
ports the role of conformational diﬀerences in these Hbs with
respect to their DPG binding site.
In summary, transgenic mice expressing hHbs exhibit an
enhanced association of the respective hHb to mRBC mem-
brane similar to that observed in hRBC. This supports the
relevance of transgenic mRBC models of human hemoglobin-
opathies.
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